Repurposing Off-Patent Drugs Through Crowd Funding with Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures

Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies. Savva Kerdemelidis: https://www.linkedin.com/in/savvak/Crowd Funded Cures: https://crowdfundedcures.org/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital